Results 151 to 160 of about 145,320 (184)

Anti-phospholipase A2 Receptor Membranous Nephropathy Presenting as Common Geriatric Complaints: A Case Report. [PDF]

Cureus
Li WTV, Wu KH, Lin OY.
europepmc   +1 more source

Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis. [PDF]

Glomerular Dis
Dibo P, Ferreira Neves HA, Konda R, Szyferman AY, Napoli F, Nnajiofor IP, Campoverde C, Razaq S, Rajasekaran A.   +8 more
europepmc   +1 more source

The PLA2R Paradox: Seropositive Membranous Nephropathy With Negative Staining. [PDF]

Kidney Int Rep
Tang X, Huang B, Zheng J, Li Y, Kang D, Zhou W, Xu F.   +6 more
europepmc   +1 more source

Dual MPO-ANCA and PLA2R positivity in crescentic glomerulonephritis with MPO-associated membranous nephropathy: a case report with pathogenic insights. [PDF]

CEN Case Rep
Morimoto C, Fujigaki Y, Anzai H, Terakawa R, Hiraike K, Asakawa S, Yamazaki O, Tamura Y, Numakura S, Ohashi R, Shibata S.   +10 more
europepmc   +1 more source

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Trillini M, Casiraghi F, Gennarini A, Portalupi V, Marasà M, Podestà MA, Prandini S, Nozza S, Todeschini M, Pecoraro F, Mister M, Carrara F, Stucchi N, Peracchi T, Fidone D, Villa A, Rubis N, Diadei O, Martinetti D, Remuzzi G, Ruggenenti P.   +20 more
europepmc   +1 more source

Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China. [PDF]

Ren Fail
Qi Y, Cao X, Gao XQ, Cheng X, Fang YX, Zhang XX, Zheng ZF, Wei L, Shang WY, Jia JY, Yan TK, Xu PC, Gu QH.   +12 more
europepmc   +1 more source

Treatment options for patients with high anti-PLA2R antibodies in primary membranous nephropathy: a single-center cohort retrospective study. [PDF]

BMC Nephrol
Cao H, Li X, Ke B.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A new fluorescence sensor developed with polydopamine nanospheres for the detection of anti-PLA2R antibody biomarkers of idiopathic membranous nephropathy

Analytical and Bioanalytical Chemistry, 2020
Anti-PLA2R antibody is only expressed in podocytes from patients with idiopathic membranous nephropathy (IMN). The detection of anti-PLA2R antibody in serum is therefore able to obtain essential information for rapid diagnosis and evaluation of the disease activity of IMN.
Linlin Li, Lu Heng, Wei Lixin
exaly   +3 more sources

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

Kidney International, 2013
Antibodies to the phospholipase A2 receptor 1 (PLA2R1) have been reported in 70% of cases of idiopathic membranous nephropathy (IMN). The genetic susceptibility of IMN has been accounted for by HLA DQA1 and PLA2R1 genes.
Edward A Mckenzie, Stephen A Roberts, Milind Nikam   +2 more
exaly   +2 more sources